January 13, 2021
Last year’s surge of digital health companies hitting the stock exchange appears to be continuing into 2021, as both Amwell and Talkspace announced public exit plans this week.
First up is Amwell, which announced Tuesday that it has created a proposed public offering to extend 11,280,647 shares of its Class A common stock to the public. Additionally, the underwriters will be given a 30-day option...
January 11, 2021
After years of telehealth investment and validation, 2020 finally saw the future of telehealth come to fruition. Across the board big telehealth companies reported a rapid adoption of the technology and financial numbers to go with it.
Amwell specifically went through a metamorphosis this year, not only seeing new market growth, but also taking the company to the public market through an IPO. ...
October 13, 2020
Digital check-in, insurance eligibility and automated patient collections technology company Clearwave today announced that it has purchased Odoro, the maker of a patient-scheduling and check-in tool. The companies did not disclose the terms of the deal, but said that they plan to integrate Odoro's scheduling technology into Clearwave's platform so that both the patient and practice can...
September 17, 2020
Amwell made its debut on the New York Stock Exchange today after announcing late Wednesday night the pricing for its upsized initial public offering of about 41.2 million shares of Class A common stock at $18 per share.
The updated pricing equates in total gross proceeds of approximately $742 million, before deducting underwriting discounts and commissions and offering expenses payable by Amwell...
September 11, 2020
AmWell and GoodRx seem to be ushering in a second wave of digital health IPOs. Why is this happening now? And who's next? With Healthbox President and HIMSS EVP Neil Patel as their guest, the MobiHealth team (host Jonah Comstock, Managing Editor Laura Lovett and Associate Editor Mallory Hackett) dive into these questions and more.
Plus, in the second half of the show, they discuss Amazon Halo,...
August 25, 2020
Telehealth giant Amwell has officially filed to go public, fueled with a $100 million funding boost from Google’s cloud division.
The funding also comes with a partnership agreement, which designates Amwell as Google Cloud's preferred telehealth provider, and vice versa for Google’s cloud platform.
The pair will also collaborate on technology, specifically bringing together AmWell’s telehealth...
June 8, 2020
Telemedicine giant AmWell is looking to go public, following a surge in use amid the coronavirus, CNBC first reported. The company declined to comment on news of the IPO when MobiHealthNews reached out.
CNBC is reporting that the Boston-based company hired Goldman Sachs and Morgan Stanley to broker the deal, which is expected to take place in September.
This news comes only weeks after the...
May 20, 2020
This morning telehealth giant Amwell raised a whopping $194 million in a Series C funding. Allianz X and Takeda were among the participants this round.
Amwell has a history of large funding rounds. In 2018 it raked it a cool $365.4 million in Series B funding, and in 2014 it raised $81 million.
This latest funding news comes as telehealth gets its era in the spotlight, as providers and...
April 21, 2020
This morning Boston-based telemedicine company Amwell (formerly American Well) announced its new virtual-health offering geared towards small and medium physician practices with less than 100 providers.
Clinicians using the platform, dubbed Amwell Private Practice, will be able to begin scheduling virtual appointments for their existing patients. Amwell also noted that the tool is currently...
November 7, 2019
Telehealth giant American Well has struck a deal to acquire Aligned Telehealth, a vendor of telepsychiatry and behavioral health that services providers and payers. American Well says that this move will make it the largest enterprise telepsychiatry platform operating in the US.
At this time, the companies are not sharing any terms of the deal such as its price, official effective date or whether...